We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
8 hedge funds and large institutions have $227K invested in Decoy Therapeutics in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
11% less funds holding
Funds holding: 9 → 8 (-1)
29% less capital invested
Capital invested by funds: $321K → $227K (-$94.7K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$106K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.95K |
| 3 |
Renaissance Technologies
New York
|
+$3.98K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.98K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$1.49K |